SCHEMBL29433780

SCHEMBL29433780

COc1cc(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
CYP1A2 P05177 1/20 0.57
KCNH2 Q12809 4/20 0.55
ALDH1A1 P00352 3/20 0.53
POLB P06746 2/20 0.53
OPRM1 P35372 2/20 0.53
HPGD P15428 2/20 0.53
HSD17B10 Q99714 2/20 0.53
PRKD3 O94806 1/20 0.53
ALOX15 P16050 1/20 0.53
CLK2 P49760 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
TOP2A P11388 5/20 0.53
TOP2B Q02880 5/20 0.53
GSK3B P49841 2/20 0.52
CHRM2 P08172 1/20 0.50
CHRM1 P11229 1/20 0.50
OPRD1 P41143 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4717958 1.00 KDM4E (0.57) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1
SCHEMBL31475494 0.89 KDM4E (0.51) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1
Hydrochloric Acid SCHEMBL31406960 0.88 KDM4E (0.50) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1
SCHEMBL4713048 0.86 KDM4E (0.52) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1
SCHEMBL4713047 0.86 KDM4E (0.52) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1
SCHEMBL4714916 0.86 KDM4E (0.52) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1
SCHEMBL28411458 0.86 TOP2A (0.58) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1
SCHEMBL13823486 0.85 KCNH2 (0.48) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1
Hydrochloric Acid SCHEMBL13823485 0.85 KCNH2 (0.47) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1
SCHEMBL4713233 0.84 KDM4E (0.60) KDM4ESMN1; SMN2CYP1A2KCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11261205-B2 Oxazolidinone-quinolone hybrid antibacterial for the parenteral treatment of prophylaxis of bacterial diseases MORPHOCHEM GMBH (DE) 2022-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11261205-B2 Oxazolidinone-quinolone hybrid antibacterial for the parenteral treatment of prophylaxis of bacterial diseases NQO2, QARS1, RECQL KDM4E 4487/4885SMN1; SMN2 1257/4885CYP1A2 645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.